Abstract
Inflammatory acne vulgaris remains one of the most common dermatologic disorders seen in clinical practice. Medical therapy remains the gold standard for therapy, but recent advances have shown that a variety of lasers and light sources may be useful in the treatment of inflammatory acne vulgaris. Furthermore, the use of 20% 5-aminolevulinic acid has found a useful niche in the treatment of moderate-to-severe inflammatory acne vulgaris.
Financial & competing interests disclosure
Michael Gold is a consultant to DUSA, Galderma, Lumenis, Hoya ConBio, Aesthera, Alma Lasers, Syneron, Cynosure, Sciton and Pharos Life; Michael Gold speaks on their behalf and has performed research on their behalf. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
